Amarin is a global pharmaceutical company committed to providing cost-effective cardiovascular care to high-risk adult cardiovascular patients, focusing on reducing the cardiovascular disease burden and advancing the science of cardiovascular care
Amarin is a global pharmaceutical company committed to providing cost-effective cardiovascular care to high-risk adult cardiovascular patients, focusing on reducing the cardiovascular disease burden and advancing the science of cardiovascular care.
The top three firms on F4's Biotech & Life Sciences investor list.